Over-the-counter (OTC) test market size was valued at $13,498.50 million in 2020, and is estimated to reach $39,937.90 million by 2030, growing at a CAGR of 11.7% from 2021 to 2030.
Over-the-Counter (OTC) is defined as the product or drugs which are available to the consumer without a prescription. Over-the-counter testing products are directly sale to the consumer, and do not require a prescription or a physician consults. It may be used in home, hospital, ambulatory surgical centers, nursing home, outpatient treatment facility and other healthcare facility, where the individual is directed to properly use the device as per product labelling.
Download Free Sample Report : https://www.alliedmarketresearch.com/request-sample/10830
The factors that drive the growth of the global over-the-counter test market include increase in the prevalence of chronic disease, technological advancements in over-the-counter testing product, and surge in demand for early diagnosis. In addition, rise in prevalence of infectious diseases such as hepatitis, pneumonia, HIV, healthcare-associated infection, & COVID-19 notably contributes toward the growth of the global OTC test market. According to the World Health Organization, in 2020, approximately 325 million individuals in the world were reported to be diagnosed with hepatitis. As per the same source, in 2019, approximately 290 million individuals in the world died from hepatitis C. This upsurge the need for HIV over-the-counter test products.
Key Market Players
- Abbott Laboratories
- Abingdon Health PLC
- AccuBioTech Co., Ltd.
- Acon Laboratories Inc.
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Clip Health
- Dario Health Corp
- Ellume Health Ltd
- Eurofins Scientific Group
- F. Hoffmann-La Roche AG
- Lia Diagnostics Inc
- Lifescan IP Holdings, LLC
- Lucira Health, Inc
- Now Diagnostics Inc
- Orasure Technologies Inc
- PHC Holdings Corporation
- Quidel Corporation
- SD Biosensor Inc.
- Sinocare Inc.
Schedule a FREE Consultation Call with Our Analysts/Industry Experts to Find Solution for Your Business : https://www.alliedmarketresearch.com/connect-to-analyst/10830
North America accounted for a majority of the global over-the-counter test market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of chronic disease, increase in number of approval for over-the-counter test product, the presence of key players, and development in technology for healthcare in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in prevalence of chronic and infectious disease, rise in number of geriatric population, growth in health care expenditures, and rise in adoption of over-the-counter test product
Key Market Segments
By Product Type
- Glucose Monitoring Test
- Blood Glucose Meters
- Testing Strips
- Lancets
- Pregnancy & Fertility Test
- Pregnancy Test
- Fertility Test
- Coagulation Monitoring Test
- Urinalysis Test
- Cholesterol Test
- Other Test
By Technology
- Lateral Flow Assays
- Immunoassays
- Dipsticks
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online pharmacy
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CUSTOMIZATION REQUEST : https://www.alliedmarketresearch.com/request-for-customization/10830